These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9538130)
1. Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice. Yoshida H; Enomoto H; Miyauchi M; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M Int J Oncol; 1998 May; 12(5):1067-71. PubMed ID: 9538130 [TBL] [Abstract][Full Text] [Related]
2. Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors. Yoshida H; Tanabe M; Miyauchi M; Kawamura K; Takenaga K; Ohnuma N; Sakiyama S; Tagawa M Cancer Gene Ther; 1999; 6(5):395-401. PubMed ID: 10505849 [TBL] [Abstract][Full Text] [Related]
3. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts. Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634 [TBL] [Abstract][Full Text] [Related]
4. Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus. Kimura M; Yoshida Y; Narita M; Takenaga K; Takenouchi T; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M Int J Cancer; 1999 Aug; 82(4):549-55. PubMed ID: 10404069 [TBL] [Abstract][Full Text] [Related]
5. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene. Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643 [TBL] [Abstract][Full Text] [Related]
6. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240 [TBL] [Abstract][Full Text] [Related]
7. Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor. Yoshida H; Enomoto H; Kawamura K; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M Int J Oncol; 1998 Jul; 13(1):73-8. PubMed ID: 9625805 [TBL] [Abstract][Full Text] [Related]
8. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376 [TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice. Enomoto A; Kato K; Yagita H; Okumura K Cancer Immunol Immunother; 1997 Jun; 44(4):204-10. PubMed ID: 9222278 [TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma. Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923 [TBL] [Abstract][Full Text] [Related]
11. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production. Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699 [TBL] [Abstract][Full Text] [Related]
12. Impaired tumorigenicity and decreased liver metastasis of murine neuroblastoma cells engineered to secrete interleukin-2 or granulocyte macrophage colony-stimulating factor. Yoshida H; Enomoto H; Tagawa M; Takenaga K; Tasaki K; Nakagawara A; Ohnuma N; Takahashi H; Sakiyama S Cancer Gene Ther; 1998; 5(2):67-73. PubMed ID: 9570297 [TBL] [Abstract][Full Text] [Related]
13. Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy. Kimura M; Tagawa M; Takenaga K; Kondo F; Yamaguchi T; Saisho H; Nakagawara A; Sakiyama S Cancer Lett; 1998 Jun; 128(1):47-53. PubMed ID: 9652792 [TBL] [Abstract][Full Text] [Related]
14. Loss of tumorigenicity of human breast cancer cells engineered to produce IL-2, IL-4 or GM-CSF in nude mice. Maeda T; Matsubara H; Sugaya M; Miyazawa Y; Gunji Y; Ochiai T; Sakiyama S; Tagawa M Int J Oncol; 1999 Nov; 15(5):943-7. PubMed ID: 10536177 [TBL] [Abstract][Full Text] [Related]
15. Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition. Matsubara H; Koide Y; Sugaya M; Gunji Y; Asano T; Ochiai T; Takegana K; Sakiyama S; Tagawa M Int J Oncol; 1998 Dec; 13(6):1217-22. PubMed ID: 9824634 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of murine colon carcinoma cells retrovirally transduced with interleukin-4 and granulocyte macrophage-colony stimulating factor genes. Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Sugaya M; Asano T; Ochiai T; Isono K; Kageyama H; Nakamura Y; Sakiyama S Oncology; 1997; 54(1):69-73. PubMed ID: 8978596 [TBL] [Abstract][Full Text] [Related]
18. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells. Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633 [TBL] [Abstract][Full Text] [Related]
19. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Watanabe Y; Kuribayashi K; Miyatake S; Nishihara K; Nakayama E; Taniyama T; Sakata T Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9456-60. PubMed ID: 2512580 [TBL] [Abstract][Full Text] [Related]
20. Immune responses to mouse neuroblastoma C1300. I. Preliminary observations on cell-mediated immune responses. Phillips ME; Cipuzak PM; Penta DD; Schachner M J Natl Cancer Inst; 1977 Oct; 59(4):1215-9. PubMed ID: 903996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]